Cempra is a clinical-stage pharmaceutical company focused on the development of antibacterial products to meet critical medical needs in the treatment of infectious bacterial diseases. The company’s product pipeline includes two leading candidates in advanced clinical development. Solithromycin, Cempra’s first candidate, is currently being evaluated in phase III clinical studies for the treatment of community […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.